4//SEC Filing
Ali Asif 4
Accession 0001104659-26-001472
CIK 0001377121other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:37 PM ET
Size
7.6 KB
Accession
0001104659-26-001472
Insider Transaction Report
Form 4
Ali Asif
Chief Financial Officer
Transactions
- Award
Common Stock
2026-01-02+25,600→ 86,665 total - Award
Stock Option (right to buy)
2026-01-02+32,000→ 32,000 totalExercise: $87.18Exp: 2036-01-02→ Common Stock (32,000 underlying)
Footnotes (2)
- [F1]Represents grant of restricted stock units payable solely in common stock that will vest in four equal annual installments on January 15, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
- [F2]The stock option vests in 48 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001921163
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:37 PM ET
- Size
- 7.6 KB